Robust amyloid clearance in a mouse model of Alzheimer's disease provides novel insights into the mechanism of amyloid-β immunotherapy
A Wang, P Das, RC Switzer, TE Golde… - Journal of …, 2011 - Soc Neuroscience
Many new therapeutics for Alzheimer's disease delay the accumulation of amyloid-β (Aβ) in
transgenic mice, but evidence for clearance of preexisting plaques is often lacking. Here, we …
transgenic mice, but evidence for clearance of preexisting plaques is often lacking. Here, we …
Robust amyloid clearance in a mouse model of Alzheimer's disease provides novel insights into the mechanism of amyloid-β immunotherapy
A Wang, P Das, RC Switzer… - Journal of …, 2011 - mayoclinic.elsevierpure.com
Many new therapeutics for Alzheimer's disease delay the accumulation of amyloid-β (Aβ) in
transgenic mice, but evidence for clearance of preexisting plaques is often lacking. Here, we …
transgenic mice, but evidence for clearance of preexisting plaques is often lacking. Here, we …
Robust amyloid clearance in a mouse model of Alzheimer's disease provides novel insights into the mechanism of amyloid-beta immunotherapy
A Wang, P Das, RC Switzer 3rd… - The Journal of …, 2011 - pubmed.ncbi.nlm.nih.gov
Many new therapeutics for Alzheimer's disease delay the accumulation of amyloid-β (Aβ) in
transgenic mice, but evidence for clearance of preexisting plaques is often lacking. Here, we …
transgenic mice, but evidence for clearance of preexisting plaques is often lacking. Here, we …
[PDF][PDF] Robust amyloid clearance in a mouse model of AD provides novel insights into the mechanism of Aβ immunotherapy
A Wang, P Das, RCS III, TE Golde, JL Jankowsky - J Neurosci, 2011 - academia.edu
Many new therapeutics for Alzheimer's disease delay the accumulation of Aβ in transgenic
mice, but evidence for clearance of pre-existing plaques is often lacking. Here we …
mice, but evidence for clearance of pre-existing plaques is often lacking. Here we …
[PDF][PDF] Robust Amyloid Clearance in a Mouse Model of Alzheimer's Disease Provides Novel Insights into the Mechanism of
A Wang, P Das, RC Switzer III, TE Golde… - The Journal of …, 2011 - Soc Neuroscience
Many new therapeutics for Alzheimer's disease delay the accumulation of amyloid-ß (Aß) in
transgenic mice, but evidence for clearance of preexisting plaques is often lacking. Here, we …
transgenic mice, but evidence for clearance of preexisting plaques is often lacking. Here, we …
Robust amyloid clearance in a mouse model of Alzheimer's disease provides novel insights into the mechanism of amyloid-beta immunotherapy.
A Wang, P Das, RC Switzer 3rd, TE Golde… - The Journal of …, 2011 - europepmc.org
Many new therapeutics for Alzheimer's disease delay the accumulation of amyloid-β (Aβ) in
transgenic mice, but evidence for clearance of preexisting plaques is often lacking. Here, we …
transgenic mice, but evidence for clearance of preexisting plaques is often lacking. Here, we …
[PDF][PDF] Robust amyloid clearance in a mouse model of AD provides novel insights into the mechanism of Aβ immunotherapy
A Wang, P Das, RCS III, TE Golde, JL Jankowsky - J Neurosci, 2011 - researchgate.net
Many new therapeutics for Alzheimer's disease delay the accumulation of Aβ in transgenic
mice, but evidence for clearance of pre-existing plaques is often lacking. Here we …
mice, but evidence for clearance of pre-existing plaques is often lacking. Here we …
[HTML][HTML] Robust Amyloid Clearance in a Mouse Model of Alzheimer's Disease Provides Novel Insights into the Mechanism of Amyloid-β Immunotherapy
A Wang, P Das, RC Switzer III, TE Golde… - The Journal of …, 2011 - ncbi.nlm.nih.gov
Many new therapeutics for Alzheimer's disease delay the accumulation of amyloid-β (Aβ) in
transgenic mice, but evidence for clearance of preexisting plaques is often lacking. Here, we …
transgenic mice, but evidence for clearance of preexisting plaques is often lacking. Here, we …
Robust amyloid clearance in a mouse model of Alzheimer's disease provides novel insights into the mechanism of amyloid-beta immunotherapy.
A Wang, P Das, RC Switzer 3rd, TE Golde… - The Journal of …, 2011 - europepmc.org
Many new therapeutics for Alzheimer's disease delay the accumulation of amyloid-β (Aβ) in
transgenic mice, but evidence for clearance of preexisting plaques is often lacking. Here, we …
transgenic mice, but evidence for clearance of preexisting plaques is often lacking. Here, we …
[HTML][HTML] Robust amyloid clearance in a mouse model of AD provides novel insights into the mechanism of Aβ immunotherapy
A Wang, P Das, RC Switzer III, TE Golde… - The Journal of …, 2011 - ncbi.nlm.nih.gov
Many new therapeutics for Alzheimer's disease delay the accumulation of Aβ in transgenic
mice, but evidence for clearance of pre-existing plaques is often lacking. Here we …
mice, but evidence for clearance of pre-existing plaques is often lacking. Here we …